Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
112.5 USD +0.84% Intraday chart for Cardinal Health, Inc. +0.58% +11.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cardinal Health Gains Approval for Science-Based Targets to Cut Greenhouse Gas Emissions MT
Transcript : Cardinal Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM
Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024 CI
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target MT
US FTC, DHHS Request Information on Shortages of Generic Drugs; McKesson Shares Ease MT
Binx health, inc. Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-Waived, FDA-Cleared binx io CI
North American Morning Briefing : Stock Futures -2- DJ
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120 MT
Cardinal Health Keeps Quarterly Dividend at $0.5006 a Share, Payable April 15 to Shareholders of Record April 1 MT
Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024 CI
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer CI
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating MT
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on June 8, 2023. CI
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on November 9, 2021. CI
Cardinal Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Cardinal Health Seeks M&A CI
Transcript : Cardinal Health, Inc., Q2 2024 Earnings Call, Feb 01, 2024
Cardinal Health's Fiscal Q2 Adjusted Earnings, Revenue Rise; Raises 2024 Guidance MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q2 Revenue $57.45B, vs. Street Est of $56.91B MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q2 EPS $1.82, vs. Street Est of $1.60 MT
North American Morning Briefing : Stock Futures -2- DJ
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET DJ
Cardinal Health Buying Specialty Networks for $1.2 Billion in Cash to Build Analytics Offerings MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET DJ
Cardinal Health to Acquire Specialty Networks for $1.2 Billion MT
Chart Cardinal Health, Inc.
More charts
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
112.5 USD
Average target price
113.3 USD
Spread / Average Target
+0.68%
Consensus
  1. Stock
  2. Equities
  3. Stock Cardinal Health, Inc. - Nyse
  4. News Cardinal Health, Inc.
  5. Cardinal Health Merging Outcomes Business Into Transaction Data Systems